Estradiol vaginal ring belongs to the class of medications called local estrogen replacement therapy. It is used for the management of vaginal and urinary menopausal symptoms such as a feeling of dryness in the vagina (with or without itching), painful intercourse, painful urination, or the feeling of needing to urinate more often than usual.
Available form
Ring
Dosage
Manufacturer
Pfizer
We won't bore you with the details, but Health Canada requires you to sign in.
By proceeding you agree to our Terms of Use & Privacy Policy
The vaginal ring can be placed in the upper third of the vagina by yourself or your doctor and worn there continuously for 90 days. It is then replaced if your treatment is to be continued.
To insert the ring yourself (as agreed upon by you and your doctor):
Most women and their partners experience no discomfort with the vaginal ring in place during intercourse, so it is not necessary that the ring be removed. If the vaginal ring should cause you or your partner any discomfort, you may remove the ring prior to intercourse. To remove the vaginal ring, wash and dry your hands thoroughly. Assume a comfortable position, either standing with one leg up, squatting, or lying down. Loop your finger through the ring and gently pull it out. Rinse the ring with lukewarm water and reinsert it as soon as possible after intercourse.
The vaginal ring may slide down into the lower part of the vagina as a result of the abdominal pressure or straining that sometimes accompanies Constipation. If this happens, gently guide the ring back into place with your finger. If the vaginal ring slips out, wash it with lukewarm water and reinsert. If the vaginal ring slips out frequently, contact your doctor.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a different dose than the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is very important to use Estring (Estradiol-vaginal) exactly as prescribed by your doctor.
Store Estring (Estradiol-vaginal) at room temperature, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who uses Estring (Estradiol-vaginal). If you are concerned about side effects, discuss the risks and benefits of Estring (Estradiol-vaginal) with your doctor.
The following side effects have been reported by at least 1% of people using Estring (Estradiol-vaginal). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop using the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are using Estring (Estradiol-vaginal).
Each slightly opaque vaginal ring, made of a silicone elastomer sheath surrounding a whitish silicone elastomer core, contains 2 mg of estradiol, barium sulfate as a marker, and silicone fluid as a dispersing agent. The estradiol is released slowly as 7.5 µg per 24 hours.
Do not use Estring (Estradiol-vaginal) if you:
There may be an interaction between the estradiol vaginal ring and any of the following:
Estradiol vaginal ring releases small amounts of estrogen locally in the vagina and drug interactions are less likely to occur with the vaginal ring than with estrogen medications taken by mouth.
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Estring (Estradiol-vaginal). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Estring (Estradiol-vaginal).
Note the following important information about estrogen replacement therapy:
The Women's Health Initiative (WHI) study results indicated an increased risk of heart attack, stroke, Breast Cancer, blood clots in the lungs, and blood clots in the leg veins in postmenopausal women during 5 years of treatment with 0.625 mg conjugated equine estrogens and 2.5 mg medroxyprogesterone compared to women receiving sugar tablets. Other combinations of estrogen and progestins were not studied. However, until additional data are available, the risks should be assumed to be similar for other hormone replacement products. Therefore,
Blood clotting disorders: Estrogens with or without progestins are associated with an increased risk of blood clots in the lungs and legs. This risk also increases with age; a personal or family history of blood clots; smoking; and Obesity. The risk of blood clots is also increased if you are immobilized for prolonged periods and with major surgery. If possible, Estring (Estradiol-vaginal) should be stopped 4 weeks before major surgery. Talk about the risk of blood clots with your doctor.
Blood pressure: Women may experience increased blood pressure when using estrogen replacement therapy. Talk to your doctor about how often you should have your blood pressure checked.
Bone disease: If you have bone disease due to cancer or a metabolic condition causing too much calcium in your body, discuss with your doctor how Estring (Estradiol-vaginal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Estring (Estradiol-vaginal), and whether any special monitoring is needed.
Breast and Ovarian Cancer: Studies indicate an increased risk of breast and ovarian cancer with the use of combined estrogen and progestin therapy. Women who have a history of breast cancer should not use estrogens. Women with a family history of breast cancer or women with a history of breast lumps, breast biopsies, or abnormal mammograms should be closely monitored by their doctor if they use estrogens. Women should have a mammogram before starting hormone replacement therapy. Women taking estrogens should have regular breast examinations and should be taught how to do a breast self-examination.
Dementia: Women over age 65 receiving combined estrogen and progestin replacement therapy may be at increased risk of developing dementia (loss of memory and intellectual function). If you are over 65, talk to your doctor about whether you should be tested for dementia.
Diabetes: If you have diabetes, your doctor should closely monitor your condition while you are taking Estring (Estradiol-vaginal), as it may affect blood sugar control.
Endometrial cancer: Medications containing estrogen increase the risk of cancer of the endometrium (lining of the uterus) in women who have had menopause. If you use any estrogen-containing medication, it is important to visit your doctor regularly and report any unusual vaginal bleeding right away.
Endometriosis: Estrogen replacement therapy can cause endometriosis to reappear or get worse. If you have or have had endometriosis, discuss with your doctor how Estring (Estradiol-vaginal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Estring (Estradiol-vaginal), and whether any special monitoring is needed.
Fibroids: Estring (Estradiol-vaginal) may worsen fibroids by causing sudden enlargement, pain, or tenderness. If you notice these effects, contact your doctor.
Fluid retention: Estrogen may cause fluid retention, and worsen heart disease, high blood pressure, Kidney Disease, or Asthma. Talk to your doctor if you have any concerns. If you experience worsening of these conditions while using Estring (Estradiol-vaginal), contact your doctor.
Follow-up examinations: It is important to have a follow-up examination 3 to 6 months after starting Estring (Estradiol-vaginal) to assess the response to treatment. Examinations should be done at least once a year after the first one.
Gallbladder: Estring (Estradiol-vaginal) can aggravate gallbladder disease or increase the risk of developing it. If you have gallbladder disease, discuss with your doctor how Estring (Estradiol-vaginal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Estring (Estradiol-vaginal), and whether any special monitoring is needed.
Heart disease and stroke: Studies indicate an increased risk of heart disease and stroke with estrogen (with or without progestin) for postmenopausal women. If you experience symptoms of a heart attack (chest pain, tightness or pressure, sweating, nausea, feeling of impending doom) or stroke (sudden dizziness, headache, loss of speech, changes in vision, weakness or numbness in the arms and legs) while taking Estring (Estradiol-vaginal), get immediate medical attention.
Liver disease: If you have liver disease, discuss with your doctor how Estring (Estradiol-vaginal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Estring (Estradiol-vaginal), and whether any special monitoring is needed. See your doctor as soon as possible if you develop signs of liver problems such as yellow eyes or skin, abdominal pain, dark urine, pale stools, or itchy skin.
Seizures: Estradiol may cause an increase in the frequency of seizures. If you have a history of Epilepsy or medical conditions that increase the risk of seizures, discuss with your doctor how Estring (Estradiol-vaginal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Estring (Estradiol-vaginal), and whether any special monitoring is needed.
Thyroid disease: Estring (Estradiol-vaginal) may affect how thyroid hormone is used by the body. If you are taking thyroid hormone for an underactive thyroid gland, discuss with your doctor how Estring (Estradiol-vaginal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Estring (Estradiol-vaginal), and whether any special monitoring is needed.
Vaginal infections: Vaginal infections should be treated by your doctor before starting Estring (Estradiol-vaginal). If a vaginal infection develops while using estradiol vaginal ring, remove the ring until the infection has cleared, and then re-insert it into the vagina.
X-ray procedures: Remove the vaginal ring before having any X-ray procedures of the lower abdominal tract. Be sure to tell all your doctors that you are using an estrogen vaginal ring.
Pregnancy: Estrogen vaginal ring must not be used during pregnancy. If you become pregnant while using Estring (Estradiol-vaginal), contact your doctor immediately.
Breast-feeding: Estring (Estradiol-vaginal) passes into breast milk. If you are a breast-feeding mother and are taking Estring (Estradiol-vaginal), it may affect your baby. Estring (Estradiol-vaginal) is not recommended for breast-feeding women.
Children: The safety and effectiveness of using Estring (Estradiol-vaginal) have not been established for children. Estring (Estradiol-vaginal) is not intended for use by children.
price lookup
Total no. of dose(s)
Manufacturer
Insurance coverage
Dosage
*Actual pricing may differ. Medication is only available by prescription. The cost may be subsidised by your provincial or private health plan.
price details
Total (CAD)
--*
Drug info not available
It’s like having us in your pocket, putting you first in every interaction.
Your medication is delivered to you at no added cost.
Call, text, email—whatever works for you. We’re humans, ready to help.
Discreet with real-time updates. Go about your day, your meds are on the way.
Your region
,
Pocketpills is licensed by
Accreditation No
#
Pharmacy Manager
2025 Pocketpills
Pocketpills is not a pharmacy
or a drug manufacturer